Kelly Patrick F. 4
4 · Forma Therapeutics Holdings, Inc. · Filed Mar 2, 2022
Insider Transaction Report
Form 4
Kelly Patrick F.
SVP, Chief Medical Officer
Transactions
- Award
Common Stock
2022-02-28+25,000→ 89,884 total - Award
Stock Option (Right to Buy)
2022-02-28+37,500→ 37,500 totalExercise: $9.86Exp: 2032-02-27→ Common Stock (37,500 underlying)
Footnotes (2)
- [F1]These shares represented restricted stock units and will be settled into common stock upon vesting. Each restricted stock unit would be converted into one share of FMTX common stock.
- [F2]25% of the shares subject to the stock option shall vest on February 28, 2023, and the remainder of the shares vest in equal monthly installments for a period of 36 months thereafter.